Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Valneva (10/08/2021)

15.08.2021

Valneva: Valneva’s total revenues were Euro 47.5 mn in the first half of 2021 compared to Euro 47.9 mn in the first half of 2020. Product sales declined by 22.4% to Euro 31.8 mn in the first half of 2021 compared to Euro 40.9 mn in the first half of 2020. Valneva recorded an operating loss of Euro 86.2 mn in the first half of 2021 compared to an operating loss of Euro 21.9 mn in the first half of 2020. EBITDA loss in the first half of 2021 was €80.1 million compared to an EBITDA loss of Euro 17.2 mn in the first half of 2020. In the first half of 2021, Valneva generated a net loss amounting to Euro 86.4 mn compared to a net loss of Euro 25.6 mn in the first half of 2020.  Thomas Lingelbach, Valneva’s Chief Executive Officer, commented, “Valneva is continuing to hit its major R&D objectives. We have just reported great results in the world’s first ever Phase 3 trial for a chikungunya vaccine alongside excellent progress for our unique COVID and Lyme disease programs. Our successful Nasdaq listing marked a significant strategic step for Valneva as we look to continue to build our Company. Our team has delivered phenomenally well this year already and I would like to thank them for their continued commitment and dedication.”
Valneva: weekly performance: -9.40%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (10/08/2021)


Partners









latest 21st Austria

21st Austria weekly - Valneva (10/08/2021)


15.08.2021, 1362 Zeichen



Valneva: Valneva’s total revenues were Euro 47.5 mn in the first half of 2021 compared to Euro 47.9 mn in the first half of 2020. Product sales declined by 22.4% to Euro 31.8 mn in the first half of 2021 compared to Euro 40.9 mn in the first half of 2020. Valneva recorded an operating loss of Euro 86.2 mn in the first half of 2021 compared to an operating loss of Euro 21.9 mn in the first half of 2020. EBITDA loss in the first half of 2021 was €80.1 million compared to an EBITDA loss of Euro 17.2 mn in the first half of 2020. In the first half of 2021, Valneva generated a net loss amounting to Euro 86.4 mn compared to a net loss of Euro 25.6 mn in the first half of 2020.  Thomas Lingelbach, Valneva’s Chief Executive Officer, commented, “Valneva is continuing to hit its major R&D objectives. We have just reported great results in the world’s first ever Phase 3 trial for a chikungunya vaccine alongside excellent progress for our unique COVID and Lyme disease programs. Our successful Nasdaq listing marked a significant strategic step for Valneva as we look to continue to build our Company. Our team has delivered phenomenally well this year already and I would like to thank them for their continued commitment and dedication.”
Valneva: weekly performance: -9.40%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (10/08/2021)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #619: Neuer bei Addiko, dad.at mit Milestone und grossem Neukundenpaket, alle Details Börsentag Wien 4.6.




 

Bildnachweis

Aktien auf dem Radar:Addiko Bank, Strabag, CA Immo, Flughafen Wien, Austriacard Holdings AG, Marinomed Biotech, ATX TR, S Immo, Porr, AT&S, Rosgix, RBI, Uniqa, ams-Osram, Cleen Energy, DO&CO, FACC, Lenzing, Oberbank AG Stamm, Agrana, Amag, Erste Group, EVN, Immofinanz, Österreichische Post, Polytec Group, Telekom Austria, VIG, Wienerberger, Zumtobel, Airbus Group.


Random Partner

Rosinger Group
Die Rosinger Group ist einer der führenden Finanzkonzerne in Mitteleuropa und in den Geschäftsfeldern "Eigene Investments" sowie "hochspezialisierte Beratungsleistungen" aktiv. Mit bisher mehr als sechzig Börsenlistings und IPOs weltweit gehört die Rosinger Group auch an der Wiener Börse zu den maßgeblichen Playern.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten